BHVN FY 2022 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena

BHVNBiohaven Ltd.

$1B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$568M

Net Income

-$570M

EPS (Diluted)

$-12.75

Cash Flow

Operating Cash Flow

-$298M

Free Cash Flow

-$339M

Stock-Based Comp.

$194M

Balance Sheet

Total Assets

$662M

Total Liabilities

$123M

Stockholders' Equity

$539M

Cash & Equivalents

$205M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$568M	-$219M	-159.4%
Net Income	-$570M	-$214M	-166.7%